Skip to content
Skip to main navigation
Skip to 1st column
Skip to 2nd column
Marijuana in Combination with Opioids for Cancer Pain
Donald Abrams, M.D.
Cannabis for Spasticity/Tremor in MS: Placebo Controlled Study
Mark Agius, M.D.
Cannabinoids in Fear Extinction
Mark Barad, M.D., Ph.D.
Treating Chemotherapy-Induced Delayed Nausea with Cannabinoids
Suzanne Dibble, DNSc, RN
MMJ for HIV-associated DSPN: Adherence & Compliance Sub-Study
Dennis Israelski, M.D.
Analgesic Efficacy of Smoked Cannabis in Refractory Cancer Pain
Mark Wallace, M.D.
New in Cannabinoid Research
Interactions between ethanol and the endocannabinoid system at GABAergic synapses on basolateral amygdala principal neurons.
There is insufficient evidence to support use of marijuana as a therapy in rheumatic disease.
Synthetic cannabinoids revealing adrenoleukodystrophy.
[P100 and N170 Components of ERPs in Abstinent Cannabinoid Users during the Modified Stroop Task].
Monoacylglycerol lipase (MGLL) polymorphism rs604300 interacts with childhood adversity to predict cannabis dependence symptoms and amygdala habituation: Evidence from an endocannabinoid system-level analysis.
New in Cannabinoid Trials
Trial of Dronabinol and Vaporized Cannabis in Neuropathic Low Back Pain
Evaluation Prospectively the Level of Reduction in Cognitive Functions of Cancer Patients Who Are on Active Oncology Treatments and Use Cannabis. The Second Goal is to Identify High-risk Groups for Cognitive Impairment Due to Cannabis Use.
Cannabis, Schizophrenia and Reward: Self-Medication and Agonist Treatment?
Integrated CBT for Cannabis Dependence With Co-occurring Anxiety Disorders
Cannabis Effects on Driving-related Skills of Young Drivers
Copyright ©2010 CENTER FOR MEDICINAL CANNABIS RESEARCH |
University of California, San Diego
| contact the